Company News Summary | 18 Feb 2021
Click the print icon in your browser to print this report. Currency is in AUD unless otherwise specified
CSL Announces Half Year Results
08:28:00 | Associate analysts
Original annuncemenet:Half Year Results Announcement
CSL announced half year results. COVID-19 continues to present challenges for its employees, its supply chains and the collection of plasma, an essential raw material used in the production of many of its therapies. The Company products are critical to sustaining patients lives, and because of this its plasma collection centers and manufacturing facilities are classified as essential services, remaining operational during the pandemic.
|This report appeared on www.morningstar.com.au||2021 Morningstar Australasia Pty Limited|
© Copyright 2021 Morningstar Australasia Pty Ltd ABN: 95 090 665 544 ("Morningstar"), AFSL no 240892. (a subsidiary of Morningstar, Inc.). This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Some of the material provided is published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO").